Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al B Benson

Showing results (111-120 of 350) with videos related to

Pageof 35
Sort By:
Clinical Colorectal Cancer|November 28, 2002
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancerJohn C Marsh, Paul Catalano, Jie Huang, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Gastrointestinal Cancer Research : GCR|April 6, 2011
Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology GroupJoanne F Rossman, Carla I Falkson, Ronghui Xu, et al.
The Oncologist|March 2, 2021
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert GroupArturo Loaiza-Bonilla, Al B Benson, Axel Grothey, et al.
American Journal of Translational Research|April 10, 2020
Dinaciclib prolongs survival in the <i>LSL-Kras</i> ; <i>LSL-Trp53</i> ; <i>Pdx-1-Cre</i> (KPC) transgenic murine models of pancreatic ductal adenocarcinomaJia Yang, Su Hu, Junjie Shangguan, et al.
Journal of Surgical Oncology|May 13, 2010
Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinomaJerome Landry, Paul J Catalano, Charles Staley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
International adaptations of NCCN Clinical Practice Guidelines in OncologyRobert W Carlson, Jonathan K Larsen, Joan McClure, et al.
American Journal of Translational Research|June 9, 2020
Prediction of therapeutic outcome and survival in a transgenic mouse model of pancreatic ductal adenocarcinoma treated with dendritic cell vaccination or CDK inhibitor using MRI texture: a feasibility studyAydin Eresen, Jia Yang, Junjie Shangguan, et al.
Cancer|June 29, 2019
Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscapeSamilia Obeng-Gyasi, Sheetal M Kircher, Kelsey P Lipking, et al.
Annals of Surgical Oncology|August 15, 2012
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United StatesKaren L Sherman, Ryan P Merkow, Karl Y Bilimoria, et al.
Pageof 35

Showing results (111-120 of 350) with videos related to

Sort By:
Pageof 35
Clinical Colorectal Cancer|November 28, 2002
Eastern Cooperative Oncology Group phase II trial (E4296) of oral 5-fluorouracil and eniluracil as a 28-day regimen in metastatic colorectal cancerJohn C Marsh, Paul Catalano, Jie Huang, et al.
American Journal of Clinical Oncology|April 2, 2014
Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group StudyBarbara Burtness, Mark Powell, Paul Catalano, et al.
Gastrointestinal Cancer Research : GCR|April 6, 2011
Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology GroupJoanne F Rossman, Carla I Falkson, Ronghui Xu, et al.
The Oncologist|March 2, 2021
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert GroupArturo Loaiza-Bonilla, Al B Benson, Axel Grothey, et al.
American Journal of Translational Research|April 10, 2020
Dinaciclib prolongs survival in the <i>LSL-Kras</i> ; <i>LSL-Trp53</i> ; <i>Pdx-1-Cre</i> (KPC) transgenic murine models of pancreatic ductal adenocarcinomaJia Yang, Su Hu, Junjie Shangguan, et al.
Journal of Surgical Oncology|May 13, 2010
Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinomaJerome Landry, Paul J Catalano, Charles Staley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 10, 2014
International adaptations of NCCN Clinical Practice Guidelines in OncologyRobert W Carlson, Jonathan K Larsen, Joan McClure, et al.
American Journal of Translational Research|June 9, 2020
Prediction of therapeutic outcome and survival in a transgenic mouse model of pancreatic ductal adenocarcinoma treated with dendritic cell vaccination or CDK inhibitor using MRI texture: a feasibility studyAydin Eresen, Jia Yang, Junjie Shangguan, et al.
Cancer|June 29, 2019
Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscapeSamilia Obeng-Gyasi, Sheetal M Kircher, Kelsey P Lipking, et al.
Annals of Surgical Oncology|August 15, 2012
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United StatesKaren L Sherman, Ryan P Merkow, Karl Y Bilimoria, et al.
Pageof 35